Presentation is loading. Please wait.

Presentation is loading. Please wait.

Inhaler reminders improve adherence with controller treatment in primary care patients with asthma  Juliet M. Foster, PhD, Tim Usherwood, BSc, MD, BS,

Published byAxel Beyer Modified over 5 years ago

Similar presentations

Presentation on theme: "Inhaler reminders improve adherence with controller treatment in primary care patients with asthma  Juliet M. Foster, PhD, Tim Usherwood, BSc, MD, BS,"— Presentation transcript:

1 Inhaler reminders improve adherence with controller treatment in primary care patients with asthma 
Juliet M. Foster, PhD, Tim Usherwood, BSc, MD, BS, Lorraine Smith, PhD, Susan M. Sawyer, MBBS, MD, Wei Xuan, MSc, MAppStat, PhD, Cynthia S. Rand, PhD, Helen K. Reddel, MBBS, PhD  Journal of Allergy and Clinical Immunology  Volume 134, Issue 6, Pages e3 (December 2014) DOI: /j.jaci Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 A, SmartTrack device installed on a fluticasone propionate/salmeterol inhaler. B, Example adherence feedback for IRF groups. The device electronically recorded the date/time of every actuation. The screen display (time since last dose taken) was seen only by patients in IRF groups. Feedback could be viewed by the IRF patient and his or her GP on a secure Web site. The graph showed the number of inhalations prescribed (dotted line) and the number of inhalations the patient took each day over a 14-day period. Patients and their GPs could access this graph on a password-protected Web site and a copy was ed to them every 30 days. Journal of Allergy and Clinical Immunology  , e3DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Flow of GPs and participants (intention-to-treat [ITT] population) through the study. The number of GPs in each intervention group who did not enroll a patient: UC = 0, PAD = 1, IRF = 1, IRF + PAD = 1. *GPs withdrew before allocation revealed and study training received. †Number of patients excluded from ITT analysis (asthma control) because of dropout or lost to follow-up before the completion of 2 or more study questionnaires. Journal of Allergy and Clinical Immunology  , e3DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 A, Mean asthma control (ACT score, primary outcome) by time point. B, Average ICS/LABA adherence over 6 months by intervention group. C, Mean ICS/LABA adherence by group and study month. D, Mean asthma quality of life (Mini AQLQ) by time point. Mini AQLQ, Mini Asthma Quality of Life Questionnaire. All GPs in all groups including UC received training in inhaler technique checking and writing an asthma action plan. All error bars 95% CIs. A change of 3 or more points in the ACT score represents a clinically important change; a score of more than 19 points represents good asthma control. Adherence monitors were activated at T0 (10.4 ± 7.3 days after patient enrolled and intervention delivered; no baseline adherence data available). A change of 0.5 or more in Mini AQLQ score represents a clinically important change. *P < Journal of Allergy and Clinical Immunology  , e3DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Inhaler reminders improve adherence with controller treatment in primary care patients with asthma  Juliet M. Foster, PhD, Tim Usherwood, BSc, MD, BS,"

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: A double-blind randomized controlled trial Saifudin.

Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: A double-blind randomized controlled trial Saifudin.
Defective B-cell memory in patients with Down syndrome Ruud H.J. Verstegen, MD, Gertjan J. Driessen, MD, Sophinus J.W. Bartol, BSc, Carel J.M. van Noesel,

Defective B-cell memory in patients with Down syndrome Ruud H.J. Verstegen, MD, Gertjan J. Driessen, MD, Sophinus J.W. Bartol, BSc, Carel J.M. van Noesel,
Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.

Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.
Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: A population-based study 

Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: A population-based study 
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial 

Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial 
Risk of an asthma exacerbation after bariatric surgery in adults

Risk of an asthma exacerbation after bariatric surgery in adults
Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo  Eli O. Meltzer, MD, Claus Bachert,

Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo  Eli O. Meltzer, MD, Claus Bachert,
A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma  L. Keoki Williams, MD, MPH,

A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma  L. Keoki Williams, MD, MPH,
Jessica P. Hollenbach, PhD, Michelle M. Cloutier, MD 

Jessica P. Hollenbach, PhD, Michelle M. Cloutier, MD 
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Montelukast treatment may alter the early efficacy of immunotherapy in children with asthma  Paweł Majak, MD, PhD, Błażej Rychlik, PhD, Łukasz Pułaski,

Montelukast treatment may alter the early efficacy of immunotherapy in children with asthma  Paweł Majak, MD, PhD, Błażej Rychlik, PhD, Łukasz Pułaski,
Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,
Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood  Zaraquiza Zolkipli, MSc,

Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood  Zaraquiza Zolkipli, MSc,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Preventive effect of nasal filters on allergic rhinitis: A randomized, double-blind, placebo- controlled crossover park study  Peter Kenney, BSc, Ole Hilberg,

Preventive effect of nasal filters on allergic rhinitis: A randomized, double-blind, placebo- controlled crossover park study  Peter Kenney, BSc, Ole Hilberg,
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Similar presentations

Ads by Google